Additionally, the production of effector molecules by tumor-infiltrating CD8+ T cells, including IFN-γ and GzmB, was remarkably increased following DS and anti-PD-1 antibody combination treatment (Fig. 6N and O), further supporting the activation of cDC1s and cytotoxic CD8+ T cells. The gene discussed is CD8A; the disease is neoplasm.